Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Roundtable on Genomics and Precision Health"'
Reflections on Sharing Clinical Trial Data : Challenges and a Way Forward: Proceedings of a Workshop
Autor:
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, Board on Health Sciences Policy, Roundtable on Genomics and Precision Health, National Cancer Policy Forum, Forum on Neuroscience and Nervous System Disorders, Forum on Drug Discovery, Development, and Translation, Carolyn Shore, Jennifer Hinners, Eeshan Khandekar, Theresa Wizemann
On November 18 and 19, 2019, the National Academies of Sciences, Engineering, and Medicine hosted a public workshop in Washington, DC, titled Sharing Clinical Trial Data: Challenges and a Way Forward. The workshop followed the release of the 2015 Ins
Autor:
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Board on Health Care Services, Roundtable on Genomics and Precision Health, National Cancer Policy Forum, Sharyl Nass, Anne Johnson, Marc Meisnere
Where people live can affect their health because of location-specific exposure to chemicals and toxicants, lifestyle, diet, immune function development, and social and historical determinants of health. A better understanding of the connections betw
Autor:
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, National Cancer Policy Forum, Board on Health Sciences Policy, Roundtable on Genomics and Precision Health, Sarah Beachy, Meredith Hackmann, Kathryn Asalone, Theresa M. Wizemann
The National Academies Roundtable on Genomics and Precision Health, in collaboration with the National Cancer Policy Forum, hosted a public workshop that examined how genomic data are used in health care, outside of the traditional settings for clini
Autor:
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Roundtable on Genomics and Precision Health, Sarah H. Beachy, Joe Alper, Siobhan Addie, Meredith Hackmann
Consumer genomics, encompassing both direct-to-consumer applications (i.e., genetic testing that is accessed by a consumer directly from a commercial company apart from a health care provider) and consumer-driven genetic testing (i.e., genetic testin
Autor:
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Roundtable on Genomics and Precision Health, Forum on Drug Discovery, Development, and Translation, Carolyn Shore, Sarah H. Beachy, Anna Nicholson, Siobhan Addie, Meredith Hackmann, Eeshan Khandekar
On March 24, 2020, a 1-day public workshop titled The Role of Digital Health Technologies in Drug Development was convened by the National Academies of Sciences, Engineering, and Medicine. This workshop builds on prior efforts to explore how virtual
Autor:
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, Board on Health Sciences Policy, Roundtable on Genomics and Precision Health, National Cancer Policy Forum, Forum on Neuroscience and Nervous System Disorders, Forum on Drug Discovery, Development, and Translation, Carolyn Shore, Amanda Wagner Gee, Sylvia Ncha, Theresa Wizemann
Sharing knowledge is what drives scientific progress - each new advance or innovation in biomedical research builds on previous observations. However, for experimental findings to be broadly accepted as credible by the scientific community, they must
Autor:
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Roundtable on Genomics and Precision Health, Sarah Beachy, Theresa Wizemann, Meredith Hackmann, Siobhan Addie
Genomic applications are being integrated into a broad range of clinical and research activities at health care systems across the United States. This trend can be attributed to a variety of factors, including the declining cost of genome sequencing
Autor:
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Roundtable on Genomics and Precision Health, Sarah H. Beachy, Joe Alper, Siobhan Addie
Genomic medicine is defined as the routine use of genomic information about an individual as part of his or her clinical care as well as the health outcomes and policy implications of that clinical use. It is one approach that has the potential to im
Autor:
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Roundtable on Genomics and Precision Health, Forum on Drug Discovery, Development, and Translation, Sarah H. Beachy, Siobhan Addie, Theresa Wizemann, Amanda Wagner Gee, Morgan L. Boname
Those involved in the drug development process face challenges of efficiency and overall sustainability due in part to high research costs, lengthy development timelines, and late-stage drug failures. Novel clinical trial designs that enroll particip